HealthSportsKSW Fighter Suspended for 4 Years After Stunning Knockout from Bottom

KSW Fighter Suspended for 4 Years After Stunning Knockout from Bottom

What a knockout! Krzysztof Glowacki delivered ⁤one of the ​most incredible knockouts of 2023, but 2024 has not been​ as kind to him.

Reuters reported ⁢on Wednesday that Glowacki has been hit with a four-year suspension from ​UK Anti-Doping after testing positive for anabolic steroids. The recent KSW fighter and former WBO cruiserweight‌ boxing champion is prohibited from participating in any athletic ​competition for the‍ duration of his suspension.

UKAD ⁤oversees anti-doping efforts for ⁢40 Olympic, Paralympic, and professional sports in ​the‌ U.K. and is ‌overseen by Parliament. The regulator complies with‍ the World Anti-Doping Code, considered​ one of the most reputable measures of anti-doping efforts.

It’s a devastating blow ⁣for Glowacki, 37, who made⁢ a successful‍ MMA debut this past June at KSW’s ⁤second ⁤“Colosseum” event⁤ at PGE⁤ Narodowy in Warsaw, Poland. Glowacki scored a miraculous KO​ from bottom position after being fully mounted, ⁤and the highlight quickly went⁣ viral, later garnering Knockout of the ‌Year consideration.

The failed drug test is not tied‌ to ‌Glowacki’s KSW appearance, ‌but rather‍ a boxing match that took place in January 2023 in Manchester, U.K. There, Glowacki lost via fourth-round TKO to Richard Riakporhe, ⁢his‌ third loss in four fights. His urine sample from that bout’s testing came up positive⁢ for Boldenone, an anabolic androgenic steroid banned at all ‌times.

Glowacki holds a 32-4 (20 KOs) record in boxing. He began his career 26-0, a run that included winning the WBO cruiserweight title in August 2015; he successfully defended it once.

» …
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Subscribe Today

GET EXCLUSIVE FULL ACCESS TO PREMIUM CONTENT

SUPPORT NONPROFIT JOURNALISM

EXPERT ANALYSIS OF AND EMERGING TRENDS IN CHILD WELFARE AND JUVENILE JUSTICE

TOPICAL VIDEO WEBINARS

Get unlimited access to our EXCLUSIVE Content and our archive of subscriber stories.

Exclusive content

Latest article

More article